A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer

Clinical trial NCT00147485 · TERMINATED

Trial details

NCT number: NCT00147485
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Lymphoma, Non-Hodgkin

Start date: 2004-12-01
Primary completion: 2007-08-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.